Geode Capital Management
ORGO icon

Geode Capital Management’s Organogenesis Holdings ORGO Stock Holding History

Geode Capital Management’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.23M Sell
1,783,964
-3,014
-0.2% -$10.4K ﹤0.01% 2823
2025
Q4 		$9.26M Buy
1,786,978
+62,346
+4% +$302K ﹤0.01% 2445
2025
Q3 		$7.28M Buy
1,724,632
+50,766
+3% +$236K ﹤0.01% 2589
2025
Q2 		$6.13M Sell
1,673,866
-30,010
-2% -$112K ﹤0.01% 2631
2025
Q1 		$7.36M Sell
1,703,876
-33,880
-2% -$137K ﹤0.01% 2468
2024
Q4 		$5.56M Sell
1,737,756
-7,694
-0.4% -$25.8K ﹤0.01% 2692
2024
Q3 		$4.99M Sell
1,745,450
-1,444
-0.1% -$4.05K ﹤0.01% 2760
2024
Q2 		$4.89M Sell
1,746,894
-1,629
-0.1% -$4.37K ﹤0.01% 2737
2024
Q1 		$4.97M Buy
1,748,523
+51,655
+3% +$176K ﹤0.01% 2709
2023
Q4 		$6.94M Buy
1,696,868
+64,806
+4% +$181K ﹤0.01% 2533
2023
Q3 		$5.19M Buy
1,632,062
+82,892
+5% +$263K ﹤0.01% 2615
2023
Q2 		$5.14M Buy
1,549,170
+36,435
+2% +$108K ﹤0.01% 2665
2023
Q1 		$3.22M Buy
1,512,735
+46,040
+3% +$114K ﹤0.01% 2825
2022
Q4 		$3.94M Buy
1,466,695
+152,502
+12% +$445K ﹤0.01% 2779
2022
Q3 		$4.26M Buy
1,314,193
+9,598
+0.7% +$43.4K ﹤0.01% 2756
2022
Q2 		$6.37M Sell
1,304,595
-26,857
-2% -$165K ﹤0.01% 2565
2022
Q1 		$10.1M Buy
1,331,452
+379,505
+40% +$2.94M ﹤0.01% 2336
2021
Q4 		$8.79M Buy
951,947
+56,486
+6% +$600K ﹤0.01% 2542
2021
Q3 		$12.8M Buy
895,461
+27,974
+3% +$434K ﹤0.01% 2293
2021
Q2 		$14.4M Buy
867,487
+137,375
+19% +$2.56M ﹤0.01% 2204
2021
Q1 		$13.3M Buy
730,112
+14,660
+2% +$199K ﹤0.01% 2154
2020
Q4 		$5.39M Buy
715,452
+335,098
+88% +$1.59M ﹤0.01% 2566
2020
Q3 		$1.46M Buy
380,354
+12,091
+3% +$47.7K ﹤0.01% 3044
2020
Q2 		$1.41M Buy
368,263
+126,158
+52% +$455K ﹤0.01% 3023
2020
Q1 		$781K Buy
242,105
+43,526
+22% +$186K ﹤0.01% 3112
2019
Q4 		$955K Buy
198,579
+22,442
+13% +$142K ﹤0.01% 3291
2019
Q3 		$1.16M Sell
176,137
-7,972
-4% -$44.4K ﹤0.01% 3177
2019
Q2 		$1.4M Buy
184,109
+50,298
+38% +$370K ﹤0.01% 3119
2019
Q1 		$1M Buy
+133,811
New +$2.67M ﹤0.01% 3161

Other funds holding ORGO

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Geode Capital Management's ORGO Position: Q1 2026 in Review

Geode Capital Management reduced its Organogenesis Holdings (ORGO) stake by 0.17% in Q1 2026, selling an estimated $10.4K and leaving 1,783,964 shares worth $4.23M. The position accounts for ﹤0.01% of the portfolio, ranked #2823.

Geode Capital Management first reported a position in ORGO in Q1 2019 and has held it in 29 quarters since. The position peaked at $14.4M in Q2 2021. 121 funds tracked by Wall St. Rank hold ORGO as of Q1 2026.

  • Geode Capital Management held 1,783,964 shares of Organogenesis Holdings worth $4.23M as of Q1 2026.
  • Geode Capital Management sold 3,014 Organogenesis Holdings shares in Q1 2026, an estimated $10.4K.
  • Organogenesis Holdings made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #2823 holding.
  • Geode Capital Management first reported a position in Organogenesis Holdings in Q1 2019 and has held it in 29 quarters since.
  • Geode Capital Management's Organogenesis Holdings position peaked at $14.4M in Q2 2021.
  • 121 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.